Cases 11 - 20 of 57
Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.
as 22-1258
Plaintiff / Appellee:
JANSSEN PHARMACEUTICALS, INC. and JANSSEN PHARMACEUTICA NV
Defendant / Appellant:
TEVA PHARMACEUTICALS USA, INC., MYLAN LABORATORIES LIMITED and MYLAN LABORATORIES LTD.
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 3:2021cv18609
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, L.L.C.
Defendant:
MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 35 U.S.C. § 145
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED
as 3:2021cv15137
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, LLC
Defendant:
MYLAN LABORATORIES LIMITED, MYLAN PHARMACEUTICALS INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 2:2020cv13103
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, LLC
Counter Claimant:
MYLAN LABORATORIES LIMITED
Defendant:
MYLAN PHARAMACEUTICALS, INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 3:2020cv13103
Plaintiff:
JANSSEN RESEARCH & DEVELOPMENT, LLC, JANSSEN PHARMACEUTICA NV and JANSSEN PHARMACEUTICALS, INC.
Defendant:
MYLAN INSTITUTIONAL LLC, MYLAN LABORATORIES LIMITED and MYLAN PHARAMACEUTICALS, INC.
Cause Of Action: 15 U.S.C. § 1126
Sanofi-Aventis U.S. LLC et al v. Actavis LLC et al
as 1:2020cv00804
Defendant:
Hetero Labs Ltd., Belcher Pharmaceuticals, LLC, Glenmark Pharmaceuticals Ltd. and others
Plaintiff:
Sanofi Mature IP and Sanofi-Aventis U.S. LLC
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Mylan Laboratories Limited
as 1:2020cv00761
Plaintiff:
Sanofi Mature IP and Sanofi-Aventis U.S. LLC
Defendant:
Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00090
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00445
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00019
Plaintiff:
Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharma GmbH & Co. KG and others
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
